TB-500 (Thymosin Beta-4) 20mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided.

For research use only — not for human or veterinary use.

Product Overview

TB-500 is a synthetic research peptide derived from a biologically active fragment of thymosin beta-4. It is studied in controlled laboratory environments for its role in cellular migration, cytoskeletal organisation and tissue-response pathway modelling. This 20 mg preparation is supplied as a lyophilized powder in a sealed 3 ml research vial and is intended exclusively for in vitro research applications.

Peptide Overview

Thymosin beta-derived peptides have been explored in research settings for several decades due to their involvement in actin dynamics and cellular structural regulation. TB-500 represents a shorter, stabilised fragment frequently utilised in laboratory models examining peptide-mediated modulation of cellular repair mechanisms and signalling behaviour under controlled experimental conditions.

Historical Background and Scientific Context

Research into thymosin-related peptides expanded significantly during the late twentieth century as scientists investigated endogenous peptides involved in tissue maintenance and cellular regeneration. TB-500 emerged within this context as a reference compound in preclinical and in vitro studies focused on cell migration, tissue-response dynamics and peptide-regulated signalling pathways.

Mechanistic Focus in Research

• Cell migration and cytoskeletal regulation studies
• Tissue-response and regenerative pathway modelling
• Peptide-mediated cellular signalling analysis
• Comparative structure–function evaluation
• Controlled in vitro biochemical investigations

Analytical and Manufacturing Notes

This TB-500 preparation is supplied as a lyophilized powder and is engineered to exceed 99 percent purity based on controlled synthesis protocols and internal quality benchmarks. Independent third-party analytical verification may be provided separately when available.

Research Applications

• Cellular repair and tissue-response research
• Cytoskeletal and actin-pathway studies
• Peptide-mediated regenerative pathway modelling
• Comparative peptide evaluation
• Controlled in vitro laboratory investigations

Grail Formula Quality

Grail Formula research peptides are produced under controlled synthesis conditions with a focus on purity, consistency and reproducibility. Each formulation is designed to support reliable laboratory research and mechanistic investigation.

When You Choose Grail Formula…

Researchers receive sealed research vials with documented handling procedures and batch identification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use

Engineered to exceed 99 percent purity
Lyophilized TB-500 supplied in a sealed 3 ml vial
Derived from thymosin beta-4 research sequences
Designed for regenerative and tissue-response studies
Produced under controlled synthesis conditions
High batch-to-batch consistency
EU shipments include bacteriostatic water
For research use only — not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.